Your browser doesn't support javascript.
[Prevention and control of SARS-CoV-2 infection in clinical laboratories: implementation of contingency plan and postpandemic response strategies].
Hang, Jianfeng; Sun, Zhaohui; Li, Linhai.
  • Hang J; Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA, Guangzhou 510010, China.
  • Sun Z; Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA, Guangzhou 510010, China.
  • Li L; Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA, Guangzhou 510010, China.
Nan Fang Yi Ke Da Xue Xue Bao ; 40(4): 606-608, 2020 Apr 30.
Artículo en Chino | MEDLINE | ID: covidwho-749258
ABSTRACT
The outbreak of COVID-19 has currently been under control in China, but now the disease has rapidly evolved into a global pandemic. We formulated a prevention and control plan for clinical laboratories responsible for detection of the novel coronavirus infection. We analyzed the implementation of this plan and the problems arising from its clinical practice. We found that the layout of most clinical laboratories (including gene amplification laboratories for clinical samples) was inadequate in response to a major outbreak and did not meet the requirements for biosafety protection and etiology and serology testing; and laboratory staff showed insufficiencies in their awareness regarding biosafety protection; the functions and status of the laboratory in the fever clinic need to be enhanced to increase its detection capacity; the high density of military personnel, the low level of automation of clinical laboratory equipment, and the lack of biosafety cabinets and personal protective equipment all limit the performance of diverse military operations and major overseas missions. In view of these problems, we propose the following strategies and

recommendations:

the clinical laboratory needs to standardize the design and staff management according to the standards of P2 laboratory; the detection capacity and staffing of fever clinic laboratory in hospitals need to be strengthened, and a separate clinical gene amplification laboratory can be optimal; for those clinical gene amplification laboratories that fail to meet these standards, reconstruction and upgrade should be made according to the requirements of biosafety protection; for the clinical laboratory in the military medical system, in addition to enforcement of biological safety protection of the staff, sufficient supply of medical materials and biological safety equipment should be ensured and biological safety cabinets should be routinely equipped if possible.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Pandemias / Betacoronavirus Tipo de estudio: Estudio de etiologia / Estudio pronóstico Límite: Humanos País/Región como asunto: Asia Idioma: Chino Revista: Nan Fang Yi Ke Da Xue Xue Bao Año: 2020 Tipo del documento: Artículo País de afiliación: J.issn.1673-4254.2020.04.25

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Pandemias / Betacoronavirus Tipo de estudio: Estudio de etiologia / Estudio pronóstico Límite: Humanos País/Región como asunto: Asia Idioma: Chino Revista: Nan Fang Yi Ke Da Xue Xue Bao Año: 2020 Tipo del documento: Artículo País de afiliación: J.issn.1673-4254.2020.04.25